Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations
The summary for the Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Assistant Secretary for Preparedness and Response, which is the U.S. government agency offering this grant.
Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations: The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), supports advanced development and availability of countermeasures for CBRN threats, pandemic influenza, and emerging infectious diseases through advanced product development, stockpile acquisition/building, manufacturing infrastructure building, and product innovation. BARDA establishes and maintains business collaborations by means of grants, cooperative agreements, and contracts with the public and private sectors, domestically and internationally. Novel influenza viruses such as H5N1 avian influenza virus, the 2009 H1N1 pandemic influenza virus and the recent H7N9 avian influenza virus are reminders of the constant threat of emergence of a massive and deadly influenza pandemic. It is widely accepted that a well-matched pandemic vaccine could significantly decrease the mortality and morbidity associated with the next pandemic. However, the global production capacity is insufficient to meet the expected pandemic response needs. Furthermore, developing countries are dependent on the availability and accessibility of vaccines manufactured by multinational producers in developed countries. BARDA has sought to increase the global pandemic influenza vaccine production capacity and supply in both developed and developing countries to allow for a global vaccine response to a severe influenza pandemic.
Federal Grant Title: | Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations |
Federal Agency Name: | Assistant Secretary for Preparedness and Response |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | EP-IDS-14-002 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.360 |
CFDA Descriptions: | Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development |
Current Application Deadline: | Aug 18, 2014 No Explanation |
Original Application Deadline: | Aug 18, 2014 No Explanation |
Posted Date: | Jul 7, 2014 |
Creation Date: | Jul 4, 2014 |
Archive Date: | Sep 17, 2014 |
Total Program Funding: | |
Maximum Federal Grant Award: | $4,000,000 |
Minimum Federal Grant Award: | $1,000,000 |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
Public and State controlled institutions of higher education
City or township governments
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
County governments
For profit organizations other than small businesses - Additional Information on Eligibility
- Non-domestic (non-U.S.) entity - Unless the authorizing legislation under which an award would be made specifically authorizes awards to foreign entities or the grant is for research (not research-related grants), foreign entities are not eligible for HHS grants
- Link to Full Grant Announcement
- Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under-Resourced Nations
- Grant Announcement Contact
- Grants.gov Contact Center
Phone Number: 1-800-518-4726
Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays.
[email protected]
Grants.gov Customer Support
Assistant Secretary for Preparedness and Response 202-245-0961 - Similar Government Grants
- • PRI Bilateral US-Israeli
- • 2019 BARDA Division of Research, Innovation and Ventures (BARDA DRIVe) Accelerator Network...
- • QUICKFIRE
- • BARDA Division of Research, Innovation and Ventures (DRIVe) Accelerator Network
- • Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Anno...
- • Opportunity EP-IDS-10-002
- • Opportunity EP-IDS-10-003
- • Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nation...
- More Grants from the Assistant Secretary for Preparedness and Response
- • Medical Reserve Corps Small Grant Program
- • MRC STTRONG
- • PRI Bilateral US-Israeli
- • Pediatric Disaster Care
- • Military- Civilian Partnership for Trauma Readiness Grant Program